安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Mallinckrodt - Home | Introducing Keenova and Par Health
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products Stay tuned for updates
- Mallinckrodt - Wikipedia
As of 1988, Mallinckrodt is the only company in the U S that is allowed to receive cocaine, which is sold as a prescription drug for use in hospitals as a local anesthetic by eye and ear, nose and throat (ENT) doctors
- Mallinckrodt, Endo become Keenova following generics spinoff
Some three months after merging, Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses
- Mallinckrodt to take over Endo in deal valued at $6. 7 billion
Ireland’s Mallinckrodt will buy U S drugmaker Endo in a cash-and-stock deal valued at $6 7 billion The companies said Thursday that Endo shareholders will receive a total of $80 million in cash and own nearly 50% of the combined company
- Mallinckrodt and Endo to Combine to Create a Global, Scaled . . .
"The combination of Mallinckrodt and Endo brings together two essential pharmaceuticals organizations to accelerate value creation for our shareholders, customers, employees, the patients we serve and our other stakeholders," said Siggi Olafsson, President and Chief Executive Officer of Mallinckrodt
- Par Health Completes Spin-Off from Mallinckrodt, Creating an . . .
LOUIS, Nov 10, 2025 PRNewswire -- Par Health, Inc ("Par Health" or the "Company") today announced that it has successfully completed its previously announced spin-off from Mallinckrodt plc
- Mallinckrodt, Endo Launch as Keenova Therapeutics Following . . .
Or on LinkedIn Mallinckrodt, Endo Launch as Keenova Therapeutics Following Merger Close; Spin Off Par Health Mallinckrodt and Endo, two specialty pharma and generics companies, have announced the next step in their merger plan, first announced in March 2025, and completed on August 1, 2025
|
|
|